Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Ingenus Pharmaceuticals GmbH
FDA Inspection
•Ingenus Pharmaceuticals GmbH•December 11, 2018

Ingenus Pharmaceuticals GmbH – FDA Inspection, Dec 11, 2018

Record Details

This FDA Inspection record concerns Ingenus Pharmaceuticals GmbH, with an inspection on December 11, 2018, issued by the Office of Inspections and Investigations, covering human drugs.

Company
Ingenus Pharmaceuticals GmbH
Inspection Date
December 11, 2018
Product Type
Human Drugs
Office
Office of Inspections and Investigations
Person
  • Yasamin Ameri (FDA Associated Person)
View Company Profile

ID · 77f0d2b8-0f1b-47cc-a2e6-7b9415943972

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1074093
FDA center
Human Drugs
Project area
Generic Drug Evaluation
Outcome
Form 483 issued

FDA Citations

7
  1. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  2. 21 CFR 211.130(e)Packaging line inspection documentation
  3. 21 CFR 211.188(b)Batch production and Batch Control Record Requirements
  4. 21 CFR 211.192Investigations of discrepancies, failures
  5. 21 CFR 211.22(a)Authority lacking to review records, investigate errors
  6. 21 CFR 211.22(d)Procedures not in writing, fully followed
  7. 21 CFR 211.63Equipment Design, Size and Location

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Ingenus Pharmaceuticals GmbH

4
DateClassificationOfficeProject area
October 3, 2024Not classifiedOffice of Inspections and Investigations
December 3, 2019NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
October 31, 2017VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 4, 2014VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Ingenus Pharmaceuticals GmbH
  • FDA Inspection 1263921 - 2024-10-03
  • FDA Inspection 1115845 - 2019-12-03
  • FDA Inspection 1034770 - 2017-10-31
  • FDA Inspection 905257 - 2014-11-04

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Ingenus Pharmaceuticals GmbH
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.